About Us
About Noxopharm
CEO's Message
Management Team
Board of Directors
Scientific Advisors
Our Network
Pharmorage
ESG Commitment
Technology
Technology Platforms
Chroma™
Sofra™
mRNA Vaccines
Autoimmune Disease
Clinical Trials
Publications
Investor Centre
Share Price
Presentations & Interviews
Annual Reports
Financial Reports
ASX Announcements
Corporate Governance
Investor Fact Sheet
Share Registry Information
Contact Us
Contact Us
Partnering
Working at Noxopharm
ASX Announcements Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Share Price
Presentations & Interviews
Annual Reports
Financial Reports
ASX Announcements
Corporate Governance
Investor Fact Sheet
Share Registry Information
ASX Announcements
Filter by Year:
2025
2024
2023
2022
2021
2020
2019
2018
Older
3 Dec 2019
Section 708 Certificate
3 Dec 2019
Appendix 3B
3 Dec 2019
AU$2.4m Increase to Funding Agreement
3 Dec 2019
Section 708 Certificate
3 Dec 2019
Appendix 3B
2 Dec 2019
Positive DARRT-1 Data in Late-Stage Prostate Cancer
28 Nov 2019
Trading Halt
26 Nov 2019
Lodgement of Nyrada Inc Prospectus - Initial Public Offering
26 Nov 2019
Lodgement of Nyrada Inc Prospectus - Initial Public Offering - Interactive
20 Nov 2019
Constitution
Previous
1
2
3
4
5
6
7
8
9
10
11
Next
